Detalhe da pesquisa
1.
Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy.
Curr Treat Options Oncol
; 22(5): 45, 2021 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864145
2.
Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy.
Int J Gynecol Cancer
; 31(1): 110-113, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796087
3.
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs.
Curr Oncol Rep
; 20(10): 76, 2018 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128845
4.
Oncological Outcomes of Patients with High-Volume mCRPC: Results from a Longitudinal Real-Life Multicenter Cohort.
Cancers (Basel)
; 15(19)2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835503
5.
Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells.
Cancers (Basel)
; 13(10)2021 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34066144
6.
Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions.
Cancers (Basel)
; 13(10)2021 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34068344
7.
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes.
Cancers (Basel)
; 12(4)2020 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235297
8.
PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?
Front Oncol
; 10: 782, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32596142
9.
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.
Sci Rep
; 10(1): 18190, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097745
10.
Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response.
Front Oncol
; 9: 1289, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31850198
11.
PARP inhibitors in ovarian cancer.
Cancer Treat Rev
; 73: 1-9, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30543930
12.
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24).
Target Oncol
; 13(4): 469-479, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948780
13.
Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.
Oncotarget
; 8(44): 76479-76491, 2017 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29100327
14.
Pancreatic neuroendocrine tumors: Nosography, management and treatment.
Int J Surg
; 28 Suppl 1: S156-62, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26708853
15.
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities.
Future Sci OA
; 7(6): FSO705, 2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046207